{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T20:27:40Z","timestamp":1792528060588,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,3,24]],"date-time":"2015-03-24T00:00:00Z","timestamp":1427155200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1038\/npp.2015.83","type":"journal-article","created":{"date-parts":[[2015,3,24]],"date-time":"2015-03-24T12:49:00Z","timestamp":1427201340000},"page":"2347-2356","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study"],"prefix":"10.1038","volume":"40","author":[{"given":"Lara A","family":"Ray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer","family":"Bujarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly E","family":"Courtney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathasha R","family":"Moallem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"Lunny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam M","family":"Leventhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Shoptaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Heinzerling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edythe D","family":"London","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Miotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,24]]},"reference":[{"key":"BFnpp201583_CR1","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.brainres.2004.06.051","volume":"1021","author":"K Anggadiredja","year":"2004","unstructured":"Anggadiredja K, Sakimura K, Hiranita T, Yamamoto T (2004). Naltrexone attenuates cue- but not drug-induced methamphetamine seeking: a possible mechanism for the dissociation of primary and secondary reward. Brain Res 1021: 272\u2013276.","journal-title":"Brain Res"},{"key":"BFnpp201583_CR2","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","volume":"295","author":"RF Anton","year":"2006","unstructured":"Anton RF, O\u2019Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM et al (2006). Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 295: 2003\u20132017.","journal-title":"JAMA"},{"key":"BFnpp201583_CR3","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/j.1530-0277.1995.tb01554.x","volume":"19","author":"MJ Bohn","year":"1995","unstructured":"Bohn MJ, Krahn DD, Staehler BA (1995). Development and initial validation of a measure of drinking urges in abstinent alcoholics. Alcohol Clin Exp Res 19: 600\u2013606.","journal-title":"Alcohol Clin Exp Res"},{"key":"BFnpp201583_CR4","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/j.1465-3362.2012.00423.x","volume":"32","author":"M Brensilver","year":"2013","unstructured":"Brensilver M, Heinzerling KG, Shoptaw S (2013). Pharmacotherapy of amphetamine-type stimulant dependence: an update. Drug Alcohol Rev 32: 449\u2013460.","journal-title":"Drug Alcohol Rev"},{"key":"BFnpp201583_CR5","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.brainresbull.2005.05.028","volume":"67","author":"CT Chiu","year":"2005","unstructured":"Chiu CT, Ma T, Ho IK (2005). Attenuation of methamphetamine-induced behavioral sensitization in mice by systemic administration of naltrexone. Brain Res Bull 67: 100\u2013109.","journal-title":"Brain Res Bull"},{"key":"BFnpp201583_CR6","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s11373-006-9102-x","volume":"13","author":"CT Chiu","year":"2006","unstructured":"Chiu CT, Ma T, Ho IK (2006). Methamphetamine-induced behavioral sensitization in mice: alterations in mu-opioid receptor. J Biomed Sci 13: 797\u2013811.","journal-title":"J Biomed Sci"},{"key":"BFnpp201583_CR7","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.biopsych.2012.01.027","volume":"72","author":"A Colasanti","year":"2012","unstructured":"Colasanti A, Searle GE, Long CJ, Hill SP, Reiley RR, Quelch D et al (2012). Endogenous opioid release in the human brain reward system induced by acute amphetamine administration. Biol Psychiatry 72: 371\u2013377.","journal-title":"Biol Psychiatry"},{"key":"BFnpp201583_CR8","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1038\/npp.2013.143","volume":"38","author":"SD Comer","year":"2013","unstructured":"Comer SD, Mogali S, Saccone PA, Askalsky P, Martinez D, Walker EA et al (2013). Effects of acute oral naltrexone on the subjective and physiological effects of oral D-amphetamine and smoked cocaine in cocaine abusers. Neuropsychopharmacology 38: 2427\u20132438.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201583_CR9","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0090-9556(25)07478-1","volume":"21","author":"CE Cook","year":"1993","unstructured":"Cook CE, Jeffcoat AR, Hill JM, Pugh DE, Patetta PK, Sadler BM et al (1993). Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride. Drug Metab Dispos 21: 717\u2013723.","journal-title":"Drug Metab Dispos"},{"key":"BFnpp201583_CR10","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0740-5472(97)00020-2","volume":"14","author":"JW Cornish","year":"1997","unstructured":"Cornish JW, Metzger D, Woody GE, Wilson D, McLellan AT, Vandergrift B et al (1997). Naltrexone pharmacotherapy for opioid dependent federal probationers. J Subst Abuse Treat 14: 529\u2013534.","journal-title":"J Subst Abuse Treat"},{"key":"BFnpp201583_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/08897070802218554","volume":"29","author":"A Elkashef","year":"2008","unstructured":"Elkashef A, Vocci F, Hanson G, White J, Wickes W, Tiihonen J (2008). Pharmacotherapy of methamphetamine addiction: an update. Subst Abus 29: 31\u201349.","journal-title":"Subst Abus"},{"key":"BFnpp201583_CR12","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.biopsych.2011.05.015","volume":"70","author":"M Fatseas","year":"2011","unstructured":"Fatseas M, Denis C, Massida Z, Verger M, Franques-Reneric P, Auriacombe M (2011). Cue-induced reactivity, cortisol response and substance use outcome in treated heroin dependent individuals. Biol Psychiatry 70: 720\u2013727.","journal-title":"Biol Psychiatry"},{"key":"BFnpp201583_CR13","unstructured":"First MB (2005). Structured Clinical Interview for DSM-IV-TR Axis I Disorders: Patient Edition. USA: Biometrics Research Department, Columbia University: New York, NY, USA."},{"key":"BFnpp201583_CR14","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2307\/2340521","volume":"85","author":"RA Fisher","year":"1922","unstructured":"Fisher RA (1922). On the interpretation of x(2) from contingency tables, and the calculation of P. J R Stat Soc 85: 87\u201394.","journal-title":"J R Stat Soc"},{"key":"BFnpp201583_CR15","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1523\/JNEUROSCI.4331-05.2006","volume":"26","author":"CP Ford","year":"2006","unstructured":"Ford CP, Mark GP, Williams JT (2006). Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location. J Neurosci 26: 2788\u20132797.","journal-title":"J Neurosci"},{"key":"BFnpp201583_CR16","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.biopsych.2010.05.003","volume":"68","author":"UE Ghitza","year":"2010","unstructured":"Ghitza UE, Preston KL, Epstein DH, Kuwabara H, Endres CJ, Bencherif B et al (2010). Brain mu-opioid receptor binding predicts treatment outcome in cocaine-abusing outpatients. Biol Psychiatry 68: 697\u2013703.","journal-title":"Biol Psychiatry"},{"key":"BFnpp201583_CR17","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.biopsych.2005.02.026","volume":"57","author":"DA Gorelick","year":"2005","unstructured":"Gorelick DA, Kim YK, Bencherif B, Boyd SJ, Nelson R, Copersino M et al (2005). Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving. Biol Psychiatry 57: 1573\u20131582.","journal-title":"Biol Psychiatry"},{"key":"BFnpp201583_CR18","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00213-008-1225-5","volume":"200","author":"DA Gorelick","year":"2008","unstructured":"Gorelick DA, Kim YK, Bencherif B, Boyd SJ, Nelson R, Copersino ML et al (2008). Brain mu-opioid receptor binding: relationship to relapse to cocaine use after monitored abstinence. Psychopharmacology (Berl) 200: 475\u2013486.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp201583_CR19","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.euroneuro.2010.06.018","volume":"20","author":"JE Grant","year":"2010","unstructured":"Grant JE, Odlaug BL, Kim SW (2010). A double-blind, placebo-controlled study of N-acetyl cysteine plus naltrexone for methamphetamine dependence. Eur Neuropsychopharmacol 20: 823\u2013828.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFnpp201583_CR20","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.bbr.2008.08.021","volume":"197","author":"J Haggkvist","year":"2008","unstructured":"Haggkvist J, Lindholm S, Franck J (2008). The opioid receptor antagonist naltrexone attenuates reinstatement of amphetamine drug-seeking in the rat. Behav Brain Res 197: 219\u2013224.","journal-title":"Behav Brain Res"},{"key":"BFnpp201583_CR21","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.bbr.2008.08.021","volume":"197","author":"J Haggkvist","year":"2009","unstructured":"Haggkvist J, Lindholm S, Franck J (2009). The opioid receptor antagonist naltrexone attenuates reinstatement of amphetamine drug-seeking in the rat. Behav Brain Res 197: 219\u2013224.","journal-title":"Behav Brain Res"},{"key":"BFnpp201583_CR22","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1038\/sj.npp.1301578","volume":"33","author":"CL Hart","year":"2008","unstructured":"Hart CL, Gunderson EW, Perez A, Kirkpatrick MG, Thurmond A, Comer SD et al (2008). Acute physiological and behavioral effects of intranasal methamphetamine in humans. Neuropsychopharmacology 33: 1847\u20131855.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201583_CR23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s002130050169","volume":"129","author":"A Herz","year":"1997","unstructured":"Herz A (1997). Endogenous opioid systems and alcohol addiction. Psychopharmacology (Berl) 129: 99\u2013111.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp201583_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1749-6632.2002.tb04156.x","volume":"965","author":"Y Itzhak","year":"2002","unstructured":"Itzhak Y, Ali SF (2002). Behavioral consequences of methamphetamine-induced neurotoxicity in mice: Relevance to the psychopathology of methamphetamine addiction. Ann N Y Acad Sci 965: 127\u2013135.","journal-title":"Ann N Y Acad Sci"},{"key":"BFnpp201583_CR25","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1176\/appi.ajp.2008.08020304","volume":"165","author":"N Jayaram-Lindstrom","year":"2008","unstructured":"Jayaram-Lindstrom N, Hammarberg A, Beck O, Franck J (2008a). Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial. Am J Psychiatry 165: 1442\u20131448.","journal-title":"Am J Psychiatry"},{"key":"BFnpp201583_CR26","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1038\/sj.npp.1301572","volume":"33","author":"N Jayaram-Lindstrom","year":"2008","unstructured":"Jayaram-Lindstrom N, Konstenius M, Eksborg S, Beck O, Hammarberg A, Franck J (2008b). Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence. Neuropsychopharmacology 33: 1856\u20131863.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201583_CR27","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1097\/01.jcp.0000144893.29987.e5","volume":"24","author":"N Jayaram-Lindstrom","year":"2004","unstructured":"Jayaram-Lindstrom N, Wennberg P, Hurd YL, Franck J (2004). Effects of naltrexone on the subjective response to amphetamine in healthy volunteers. J Clin Psychopharmacol 24: 665\u2013669.","journal-title":"J Clin Psychopharmacol"},{"key":"BFnpp201583_CR28","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/FBP.0b013e3283423d55","volume":"22","author":"C Jimenez-Gomez","year":"2011","unstructured":"Jimenez-Gomez C, Winger G, Dean RL, Deaver DR, Woods JH (2011). Naltrexone decreases D-amphetamine and ethanol self-administration in rhesus monkeys. Behav Pharmacol 22: 87\u201390.","journal-title":"Behav Pharmacol"},{"key":"BFnpp201583_CR29","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bcp.2007.08.005","volume":"75","author":"BA Johnson","year":"2008","unstructured":"Johnson BA (2008). Update on neuropharmacological treatments for alcoholism: Scientific basis and clinical findings. Biochem Pharmacol 75: 34\u201356.","journal-title":"Biochem Pharmacol"},{"key":"BFnpp201583_CR30","first-page":"232","volume":"1","author":"MJ Kreek","year":"1996","unstructured":"Kreek MJ (1996). Opiates, opioids and addiction. Mol Psychiatry 1: 232\u2013254.","journal-title":"Mol Psychiatry"},{"key":"BFnpp201583_CR31","first-page":"1207","volume":"29","author":"MC Lee","year":"1988","unstructured":"Lee MC, Wagner HN Jr, Tanada S, Frost JJ, Bice AN, Dannals RF (1988). Duration of occupancy of opiate receptors by naltrexone. J Nucl Med 29: 1207\u20131211.","journal-title":"J Nucl Med"},{"key":"BFnpp201583_CR32","first-page":"343","volume":"22","author":"J Levine","year":"1986","unstructured":"Levine J, Schooler NR (1986). SAFTEE: a technique for the systematic assessment of side effects in clinical trials. Psychopharmacol Bull 22: 343\u2013381.","journal-title":"Psychopharmacol Bull"},{"key":"BFnpp201583_CR33","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/j.1369-1600.2012.00454.x","volume":"17","author":"RZ Litten","year":"2012","unstructured":"Litten RZ, Egli M, Heilig M, Cui C, Fertig JB, Ryan ML et al (2012). Medications development to treat alcohol dependence: a vision for the next decade. Addict Biol 17: 513\u2013527.","journal-title":"Addict Biol"},{"key":"BFnpp201583_CR34","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1111\/j.1530-0277.2006.00159.x","volume":"30","author":"J MacKillop","year":"2006","unstructured":"MacKillop J (2006). Factor structure of the alcohol urge questionnaire under neutral conditions and during a cue-elicited urge state. Alcohol Clin Exp Res 30: 1315\u20131321.","journal-title":"Alcohol Clin Exp Res"},{"key":"BFnpp201583_CR35","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/978-3-642-28720-6_201","volume":"13","author":"BJ Mason","year":"2013","unstructured":"Mason BJ, Higley AE (2013). A translational approach to novel medication development for protracted abstinence. Curr Top Behav Neurosci 13: 647\u2013670.","journal-title":"Curr Top Behav Neurosci"},{"key":"BFnpp201583_CR36","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1017\/S1461145714000704","volume":"17","author":"I Mick","year":"2014","unstructured":"Mick I, Myers J, Stokes PR, Erritzoe D, Colasanti A, Bowden-Jones H et al (2014). Amphetamine induced endogenous opioid release in the human brain detected with [11C]carfentanil PET: replication in an independent cohort. Int J Neuropsychopharmacol 17: 2069\u20132074.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFnpp201583_CR37","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1037\/0021-843X.96.2.122","volume":"96","author":"PM Monti","year":"1987","unstructured":"Monti PM, Binkoff JA, Abrams DB, Zwick WR, Nirenberg TD, Liepman MR (1987). Reactivity of alcoholics and nonalcoholics to drinking cues. J Abnorm Psychol 96: 122\u2013126.","journal-title":"J Abnorm Psychol"},{"key":"BFnpp201583_CR38","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00213-012-2954-z","volume":"227","author":"ME Morean","year":"2013","unstructured":"Morean ME, de Wit H, King AC, Sofuoglu M, Rueger SY, O\u2019Malley SS (2013). The drug effects questionnaire: psychometric support across three drug types. Psychopharmacology (Berl) 227: 177\u2013192.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp201583_CR39","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1017\/S1461145708009097","volume":"11","author":"TF Newton","year":"2008","unstructured":"Newton TF, Reid MS, De La Garza R, Mahoney JJ, Abad A, Condos R et al (2008). Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers. Int J Neuropsychopharmacol 11: 1037\u20131045.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFnpp201583_CR40","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1038\/sj.npp.1300979","volume":"31","author":"TF Newton","year":"2006","unstructured":"Newton TF, Roache JD, De La Garza R 2nd, Fong T, Wallace CL, Li SH et al (2006). Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving. Neuropsychopharmacology 31: 1537\u20131544.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201583_CR41","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1001\/archpsyc.1992.01820110045007","volume":"49","author":"SS O\u2019Malley","year":"1992","unstructured":"O\u2019Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B (1992). Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Arch Gen Psychiatry 49: 881\u2013887.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp201583_CR42","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/00004714-200002000-00012","volume":"20","author":"SS O\u2019Malley","year":"2000","unstructured":"O\u2019Malley SS, Krishnan-Sarin S, Farren C, O\u2019Connor PG (2000). Naltrexone-induced nausea in patients treated for alcohol dependence: clinical predictors and evidence for opioid-mediated effects. J Clin Psychopharmacol 20: 69\u201376.","journal-title":"J Clin Psychopharmacol"},{"key":"BFnpp201583_CR43","doi-asserted-by":"publisher","first-page":"3843","DOI":"10.1007\/s00213-014-3519-0","volume":"231","author":"LA Ray","year":"2014","unstructured":"Ray LA, Courtney KE, Ghahremani DG, Miotto K, Brody A, London ED (2014a). Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings. Psychopharmacology (Berl) 231: 3843\u20133853.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp201583_CR44","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3109\/00952990.2014.927881","volume":"41","author":"LA Ray","year":"2014","unstructured":"Ray LA, Courtney KE, Ghahremani DG, Miotto K, Brody A, London ED (2014b). Varenicline, naltrexone, and their combination for heavy-drinking smokers: preliminary neuroimaging findings. Am J Drug Alcohol Abuse 41: 35\u201344.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"BFnpp201583_CR45","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.2174\/138161210791516422","volume":"16","author":"LA Ray","year":"2010","unstructured":"Ray LA, Hutchison KE, Tartter M (2010). Application of human laboratory models to pharmacotherapy development for alcohol dependence. Curr Pharm Des 16: 2149\u20132158.","journal-title":"Curr Pharm Des"},{"key":"BFnpp201583_CR46","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1046\/j.1471-4159.1996.67062292.x","volume":"67","author":"CA Schad","year":"1996","unstructured":"Schad CA, Justice JB Jr., Holtzman SG (1996). Differential effects of delta- and mu-opioid receptor antagonists on the amphetamine-induced increase in extracellular dopamine in striatum and nucleus accumbens. J Neurochem 67: 2292\u20132299.","journal-title":"J Neurochem"},{"key":"BFnpp201583_CR47","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1001\/jamapsychiatry.2013.762","volume":"70","author":"D Seo","year":"2013","unstructured":"Seo D, Lacadie CM, Tuit K, Hong KI, Constable RT, Sinha R (2013). Disrupted ventromedial prefrontal function, alcohol craving, and subsequent relapse risk. JAMA Psychiatry 70: 727\u2013739.","journal-title":"JAMA Psychiatry"},{"key":"BFnpp201583_CR48","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/j.1360-0443.1988.tb00485.x","volume":"83","author":"LC Sobell","year":"1988","unstructured":"Sobell LC, Sobell MB, Leo GI, Cancilla A (1988). Reliability of a timeline method: assessing normal drinkers\u2019 reports of recent drinking and a comparative evaluation across several populations. Br J Addict 83: 393\u2013402.","journal-title":"Br J Addict"},{"key":"BFnpp201583_CR49","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA) (2013) Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-46, HHS Publication No. (SMA) 13-4795. Substance Abuse and Mental Health Services Administration: Rockville, MD, USA."},{"key":"BFnpp201583_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0014-2999(97)01020-0","volume":"331","author":"T Suzuki","year":"1997","unstructured":"Suzuki T, Mori T, Tsuji M, Misawa M, Nagase H (1997). The role of delta-opioid receptors in the discriminative stimulus properties of a low dose of methamphetamine. Eur J Pharmacol 331: 1\u20138.","journal-title":"Eur J Pharmacol"},{"key":"BFnpp201583_CR51","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.15288\/jsad.2011.72.1012","volume":"72","author":"R Swift","year":"2011","unstructured":"Swift R, Oslin DW, Alexander M, Forman R (2011). Adherence monitoring in naltrexone pharmacotherapy trials: a systematic review. J Stud Alcohol Drugs 72: 1012\u20131018.","journal-title":"J Stud Alcohol Drugs"},{"key":"BFnpp201583_CR52","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1176\/appi.ajp.2011.11071121","volume":"169","author":"J Tiihonen","year":"2012","unstructured":"Tiihonen J, Krupitsky E, Verbitskaya E, Blokhina E, Mamontova O, Fohr J et al (2012). Naltrexone implant for the treatment of polydrug dependence: a randomized controlled trial. Am J Psychiatry 169: 531\u2013536.","journal-title":"Am J Psychiatry"},{"key":"BFnpp201583_CR53","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3109\/00952991003686402","volume":"36","author":"BK Tolliver","year":"2010","unstructured":"Tolliver BK, McRae-Clark AL, Saladin M, Price KL, Simpson AN, DeSantis SM et al (2010). Determinants of cue-elicited craving and physiologic reactivity in methamphetamine-dependent subjects in the laboratory. Am J Drug Alcohol Abuse 36: 106\u2013113.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"BFnpp201583_CR54","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1001\/archpsyc.1992.01820110040006","volume":"49","author":"JR Volpicelli","year":"1992","unstructured":"Volpicelli JR, Alterman AI, Hayashida M, O\u2019Brien CP (1992). Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49: 876\u2013880.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp201583_CR55","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/sj.npp.1301440","volume":"33","author":"EM Weerts","year":"2008","unstructured":"Weerts EM, Kim YK, Wand GS, Dannals RF, Lee JS, Frost JJ et al (2008). Differences in delta- and mu-opioid receptor blockade measured by positron emission tomography in naltrexone-treated recently abstinent alcohol-dependent subjects. Neuropsychopharmacology 33: 653\u2013665.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201583_CR56","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.pbb.2006.07.028","volume":"85","author":"J Zalewska-Kaszubska","year":"2006","unstructured":"Zalewska-Kaszubska J, Gorska D, Dyr W, Czarnecka E (2006). Effect of acute administration of ethanol on beta-endorphin plasma level in ethanol preferring and non-preferring rats chronically treated with naltrexone. Pharmacol Biochem Behav 85: 155\u2013159.","journal-title":"Pharmacol Biochem Behav"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp201583.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp201583","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp201583.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T14:13:07Z","timestamp":1747836787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp201583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,24]]},"references-count":56,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["BFnpp201583"],"URL":"https:\/\/doi.org\/10.1038\/npp.2015.83","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,24]]},"assertion":[{"value":"8 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}